1. Clinical Oncohematology: Guidelines for Physicians, Volkova MA, ed. Moscow, 2007. Russian.
2. Dolgikh TJ, Domnikova NP, Kachesov IV, Marchenko AA. Patent RF No. 2552928. Method of automated morphometric myelofibrosis diagnostics. Bull. No. 16 (June 10, 2015). Russian.
3. Rugal V, Bessmeltsev S, Semenova N. Niche formed structures and bone marrow stroma characteristics of patients with chronic lymphocytic leukemia.Medline.Ru. 2013;14:347-361.
4. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981; 48(1):198-206.
5. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell. 1998; 93(7):1159-1170.